GSK-3beta inhibitor 11 (compound 21) is a potent glycogen synthase kinase-3beta (GSK-3beta) inhibitor with an IC50 of 10.02 µM, demonstrating potential utility in neurodegenerative disease research [1].
Molecular Weight:
393.42
Purity:
97.40%
CAS Number:
[536731-65-4]
Formula:
C20H15N3O4S
Target:
GSK-3
T61809
* VAT and and shipping costs not included. Errors and price changes excepted